drug
(artemether + lumefantrine)
Marketedupdated 3mo agoby $NVS NOVARTIS AG
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying (artemether + lumefantrine)
- phase4Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated Malaria
- phase2To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria
- phase2Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2)
- phase3Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria
- phase2Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
- phase2Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 25m ago
Found something off?
comments(0)
5-min edit window · permanent after that